RankingsPricing
  1. JP-listed companies
  2. SAPPORO CLINICAL LABORATORY INC.
  3. Financials
  4. Operating income

SAPPORO CLINICAL LABORATORY INC.JP:9776

Market cap
¥8.3B
P/E ratio
12.2x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Mar 31, 2025706+32.22%
Mar 31, 2024534-47.02%
Mar 31, 20231,008-34.42%
Mar 31, 20221,537+34.59%
Mar 31, 20211,142+20.85%
Mar 31, 2020945+15.88%
Mar 31, 2019815-19.82%
Mar 31, 20181,017+31.78%
Mar 31, 2017772-20.79%
Mar 31, 2016974+12.03%
Mar 31, 2015870

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)